Adjustable thermoplastic mandibular advancement device for obstructive sleep apnea: Outcomes and practicability

Banhiran, Wish; Kittiphumwong, Phantipar; Assanasen, Paraya; Chongkolwatana, Cheerasook; Metheetrairut, Choakchai

doi:10.1002/lary.24607

Cited by 26 publications

(26 citation statements)

References 26 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…In this case the device was inserted at a maximum protrusion of 60%, applying 0.5‐ to 1‐mm increments every 2 weeks. Banhiran et al found a significant reduction in AHI in 60.9% patients with AHI < 5 (of whom 75% presented moderate OSAHS). These authors used adjustable MADs and applied 0.5‐ to 1‐mm increments every 1 or 2 weeks for 4 to 6 months.…”

Section: Discussionmentioning

confidence: 96%

Effectiveness of mandibular advancement appliances in treating obstructive sleep apnea syndrome: A systematic review

Serra-Torres¹,

Bellot-Arcís²,

Montiel-Company³

et al. 2015

The Laryngoscope

View full text Add to dashboard Cite

show abstract

Section: Discussionmentioning

confidence: 96%

Effectiveness of mandibular advancement appliances in treating obstructive sleep apnea syndrome: A systematic review

Serra-Torres¹,

Bellot-Arcís²,

Montiel-Company³

et al. 2015

The Laryngoscope

View full text Add to dashboard Cite

show abstract

“…For the purpose of comparison with previously published studies in patients with moderate‐to‐severe OSA, a complete response was defined as post‐treatment AHI < 5/hr, good response as post‐treatment AHI < 10/hr but > 5/hr, and treatment failure as ongoing AHI ≥10/hr. However, we were stricter and added ESS ≤10 to the concepts of complete and good response and ESS >10 to the concept of treatment failure.…”

Section: Methodsmentioning

confidence: 99%

Impact of an oral appliance on obstructive sleep apnea severity, quality of life, and biomarkers

et al. 2017

View full text Add to dashboard Cite

show abstract

“…They can be designed to monobloc or duobloc, depending on whether the MAD is composed of 1 or 2 pieces. [13,14] …”

Section: Introductionmentioning

confidence: 99%

Therapeutic outcomes of mandibular advancement devices as an initial treatment modality for obstructive sleep apnea

et al. 2016

View full text Add to dashboard Cite

Although continuous positive airway pressure (CPAP) is a highly efficacious treatment for obstructive sleep apnea (OSA), there is a need for alternative treatment options, such as sleep surgeries and mandibular advancement devices (MADs), to overcome the limitations of CPAP.This study aimed to analyze the therapeutic outcomes of OSA subjects who were treated with a MAD, and to estimate the clinical impact of MAD as a first-line treatment for OSA.Forty-seven patients diagnosed with OSA received an adjustable MAD as an initial treatment. Drug-induced sleep endoscopic findings and sleep parameters (both pre-MAD and post-MAD treatment), such as apnea index, oxygen saturation, and degree of daytime sleepiness, were assessed retrospectively.The MAD treatment resulted in a significant reduction in apnea–hypopnea index, and also a significant elevation in lowest oxygen saturation. Satisfactory results of MAD treatment as a first treatment modality were observed in 27 patients, and a successful outcome was reached in approximately 72% of patients. The OSA patients who had lower body mass index and upper airway narrowing at the level of palate and tongue base showed relatively higher rates of a satisfactory outcome even in cases of moderate or severe OSA.These results suggest that the use of a MAD may be an alternative treatment option in OSA patients with retropalatal and retroglossal area narrowing regardless of disease severity. Additionally, MADs can be recommended as an initial treatment modality, and the effectiveness of MADs in achieving success may not be inferior to CPAP.

show abstract

Adjustable thermoplastic mandibular advancement device for obstructive sleep apnea: Outcomes and practicability

Abstract: This is the first study in Asians demonstrating that an AT-MAD, if done properly, is a practical short-term treatment of OSA, with good outcomes including improved QOL. Its advantages are its low cost and ready-to-use nature. However, further randomized controlled trials are required.

Cited by 26 publications

References 26 publications

Effectiveness of mandibular advancement appliances in treating obstructive sleep apnea syndrome: A systematic review

Effectiveness of mandibular advancement appliances in treating obstructive sleep apnea syndrome: A systematic review

Impact of an oral appliance on obstructive sleep apnea severity, quality of life, and biomarkers

Therapeutic outcomes of mandibular advancement devices as an initial treatment modality for obstructive sleep apnea

Contact Info

Product

Resources

About